First, Ang IV treatment dose-dependently attenuated left ventricular dysfunction, remodeling, fibrosis, and myocyte apoptosis in a mouse model of diabetic cardiomyopathy. This evidence concerns the gene AGT and diabetic cardiomyopathy.